Literature DB >> 28289340

Eosinophilic Esophagitis: an Emerging Clinicopathologic Disease of Children and Adults.

Glenn T Furuta1, Alex Straumann1.   

Abstract

Eosinophililc esophagitis is a clinicopathologic disease characterized clinically by dysphagia and food impaction in adults and nonspecific symptoms of gastroesophageal reflux disease in children, and histologically by large numbers of eosinophils in the proximal and distal esophageal epithelium. Importantly, these symptoms and histologic abnormalities appear to be unresponsive to proton pump inhibition. Recent clinical and basic studies suggest an allergic etiology but the precise allergen remains unknown and is likely unique for each patient. Endoscopic features suggest ongoing inflammation and range from linear furrowing with whitish exudation to long-segment stricture formation, to a fragile, crepe paper-like mucosa that is easily split open. Treatments include nutritional restrictions, medical management with topical steroids, and, in stenotic circumstances, esophageal dilation. The long-term outcome is still not certain.

Entities:  

Keywords:  Eosinophil; allergic esophagitis; dysphagia; esophageal stricture; food impaction; interleukin-5

Year:  2006        PMID: 28289340      PMCID: PMC5338190     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN: 1554-7914


  31 in total

1.  A novel endoscopic appearance of idiopathic eosinophilic esophagitis.

Authors:  A Ahmed; S Matsui; R Soetikno
Journal:  Endoscopy       Date:  2000-06       Impact factor: 10.093

2.  Use of an anti-interleukin-5 antibody in the hypereosinophilic syndrome with eosinophilic dermatitis.

Authors:  Sabine-Gisela Plötz; Hans-Uwe Simon; Ulf Darsow; Dagmar Simon; Ekatherina Vassina; Shida Yousefi; Rüdiger Hein; Tim Smith; Heidrun Behrendt; Johannes Ring
Journal:  N Engl J Med       Date:  2003-12-11       Impact factor: 91.245

3.  Primary eosinophilic esophagitis in children: successful treatment with oral corticosteroids.

Authors:  C A Liacouras; W J Wenner; K Brown; E Ruchelli
Journal:  J Pediatr Gastroenterol Nutr       Date:  1998-04       Impact factor: 2.839

4.  Association of eosinophilic inflammation with esophageal food impaction in adults.

Authors:  Tusar K Desai; Veslav Stecevic; Chung-Ho Chang; Neal S Goldstein; Kamran Badizadegan; Glenn T Furuta
Journal:  Gastrointest Endosc       Date:  2005-06       Impact factor: 9.427

5.  Topical corticosteroid treatment of dysphagia due to eosinophilic esophagitis in adults.

Authors:  Amindra S Arora; Jean Perrault; Thomas C Smyrk
Journal:  Mayo Clin Proc       Date:  2003-07       Impact factor: 7.616

6.  Eosinophilic esophagitis attributed to gastroesophageal reflux: improvement with an amino acid-based formula.

Authors:  K J Kelly; A J Lazenby; P C Rowe; J H Yardley; J A Perman; H A Sampson
Journal:  Gastroenterology       Date:  1995-11       Impact factor: 22.682

Review 7.  Eosinophilic esophagitis: asthma of the esophagus?

Authors:  Amindra S Arora; Kiyoshi Yamazaki
Journal:  Clin Gastroenterol Hepatol       Date:  2004-07       Impact factor: 11.382

8.  [Eosinophilic esophagitis, a rare manifestation of eosinophilic gastroenteritis].

Authors:  R Münch; U Kuhlmann; M Makek; R Ammann; W Siegenthaler
Journal:  Schweiz Med Wochenschr       Date:  1982-05-15

9.  Anti-interleukin-5 (mepolizumab) therapy for hypereosinophilic syndromes.

Authors:  Jennifer K Garrett; Sean C Jameson; Blythe Thomson; Margaret H Collins; Lynne E Wagoner; Debbie K Freese; Lisa A Beck; Joshua A Boyce; Alexandra H Filipovich; Joyce M Villanueva; Steven A Sutton; Amal H Assa'ad; Marc E Rothenberg
Journal:  J Allergy Clin Immunol       Date:  2003-12-12       Impact factor: 10.793

10.  Clinical and endoscopic features of eosinophilic esophagitis in adults.

Authors:  John Croese; Stephen K Fairley; John W Masson; André K H Chong; David A Whitaker; Peter A Kanowski; Neal I Walker
Journal:  Gastrointest Endosc       Date:  2003-10       Impact factor: 9.427

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.